Brussels, 30 January 2025
The EU Commission has today launched a new Biotech and Biomanufacturing Hub to support companies – particularly start-ups and SMEs – in bringing innovative products to the EU market and increase their competitiveness. The Hub will also help companies identify the support available to them at EU level and how to access this support to help them to expand and grow.
The Biotech and Biomanufacturing Hub explains in an easy, accessible way and in all EU languages:
- The sources of EU funding available to biotech and biomanufacturing companies;
- The research infrastructures that can support biotech or biomanufacturing Research & Development;
- The resources available to help biotech or biomanufacturing businesses to scale up, including networks, pilot and testing facilities and market insights;
- The intellectual property protection that innovative companies are entitled to;
- The processes for authorising new biotech products, such as human and veterinary medicines or feed and food ingredients, and the support offered to applicants throughout these processes;
- The rules and requirements that companies must comply with when developing and marketing biotech products in the EU.
The Hub, hosted on the Commission’s Your Europe portal, will serve as an operational tool for easy and accessible information on the relevant EU legislation, financing opportunities and business support networks, such as the Enterprise Europe Network and European Cluster Collaboration Platform.
The continuous development of the Hub will be supported through a dedicated taskforce of small and medium-sized enterprises advisors under the Enterprise Europe Network.
Biotechnology is one of the fastest growing innovative industries in the EU, which has the potential to revolutionise health, agriculture, food and feed and industry in Europe over the coming years. A thriving biotechnology and biomanufacturing sector will be key to building a more competitive, innovative and resilient EU, that succeeds in its green and digital transitions.
Background
The Biotech and Biomanufacturing Hub is a key deliverable of the Commission’s Strategy to boost biotechnology and biomanufacturing in the EU. This Strategy, published in March 2024, announced the establishment of the Hub to better support scale-up and to ease navigating regulations.
More information
Quote(s)
Biotechnology is a key driver of industrial innovation, competitiveness and productivity, while using fewer resources, producing less emissions and generating less waste. From advancing healthcare solutions to bio-based products in sectors such as chemicals, food, detergents, paper&pulp and textiles, biotech holds transformative potential for scaling up Europe’s industrial production and increasing prosperity. The EU is set to create an optimal environment to support its scale-up, ensuring this critical sector thrives for the benefit of our citizens and industries alike. The Hub is a practical tool that will support this.
Biotechnology has a fundamental role in boosting the EU’s competitiveness and embracing innovation and technology, shaping the future of European healthcare. Artificial intelligence can help us to transform biotechnology for the discovery and development of life-saving therapies, to better prevent and predict diseases, and to make personalised and patient-centred medicine a reality. The Commission is committed to unlocking the full potential of biotech and to helping this critical sector to grow for the benefit of our citizens and businesses.
Source – EU Commission